Hodgkin's lymphoma pathophysiology: Difference between revisions

	Hodgkin's lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hodgkin's lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray Findings
CT
MRI
Ultrasound
Biopsy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hodgkin's lymphoma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hodgkin's lymphoma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hodgkin's lymphoma pathophysiology
CDC on Hodgkin's lymphoma pathophysiology
Hodgkin's lymphoma pathophysiology in the news
Blogs on Hodgkin's lymphoma pathophysiology
Directions to Hospitals Treating Hodgkin's lymphoma
Risk calculators and risk factors for Hodgkin's lymphoma pathophysiology

VisualWikitext

Revision as of 21:32, 30 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Pathophysiology

Gross Pathology

Affected lymph nodes (most often, laterocervical lymph nodes) are enlarged, but their shape is preserved because the capsule is not invaded. Usually, the cut surface is white-grey and uniform; in some histological subtypes (e.g. nodular sclerosis) may appear a nodular aspect

Microscopic Pathology

Microscopic examination of the lymph node biopsy reveals complete or partial effacement of the lymph node architecture by scattered large malignant cells known as Reed-Sternberg cells (typical and variants) admixed within a reactive cell infiltrate composed of variable proportions of lymphocytes, histiocytes, eosinophils, and plasma cells. The Reed-Sternberg cells are identified as large often bi-nucleated cells with prominent nucleoli and an unusual CD45-, CD30+, CD15+/- immunophenotype. In approximately 50% of cases, the Reed-Sternberg cells are infected by the Epstein-Barr virus.

Characteristics of classic Reed-Sternberg cells include large size (20–50 micrometres), abundant, amphophilic, finely granular/homogeneous cytoplasm; two mirror-image nuclei (owl eyes) each with an eosinophilic nucleolus and a thick nuclear membrane (chromatin is distributed at the cell periphery).

Variants:

Hodgkin's cell (atypical mononuclear RSC) is a variant of RS cell, which has the same characteristics, but is mononucleated.
Lacunar RSC is large, with a single hyperlobated nucleus, multiple, small nucleoli and eosinophilic cytoplasm which is retracted around the nucleus, creating an empty space ("lacunae").
Pleomorphic RSC has multiple irregular nuclei.
"Popcorn" RSC (lympho-histiocytic variant) is a small cell, with a very lobulated nucleus, small nucleoli.
"Mummy" RSC has a compact nucleus, no nucleolus and basophilic cytoplasm. ^[2]

Hodgkin's lymphoma can be sub-classified by histological type. The cell histology in Hodgkin's lymphoma is not as important as it is in non-Hodgkin's lymphoma: the treatment and prognosis in Hodgkin's lymphoma depend on the stage of disease rather than the histotype.

References

Template:WikiDoc Sources

[1] ttp://picasaweb.google.com/mcmumbi/USMLEIIImages

[2] [1]

[1]

[2]

@@ Line 24: / Line 24: @@
 Hodgkin's lymphoma can be sub-classified by histological type.  The cell histology in Hodgkin's lymphoma is not as important as it is in [[non-Hodgkin's lymphoma]]: the treatment and prognosis in Hodgkin's lymphoma depend on the stage of disease rather than the histotype.
-=== Staging ===
-After Hodgkin's lymphoma is diagnosed, a patient will be ''[[Cancer staging|staged]]'': that is, they will undergo a series of tests and procedures which will determine what areas of the body are affected. These procedures will include documentation of their histology, a physical examination, blood tests, chest [[X-ray]] radiographs, [[computed tomography]] (CT) scans or [[magnetic resonance imaging]] (MRI) scans of the chest, abdomen and pelvis, and a bone marrow biopsy. [[Positron emission tomography]] (PET) scan is now used instead of the [[gallium scan]] for staging.  In the past, a [[lymphangiogram]] or surgical [[laparotomy]] (which involves opening the abdominal cavity and visually inspecting for tumors) were performed.  Lymphangiograms or laparotomies are very rarely performed, having been supplanted by improvements in imaging with the CT scan and PET scan.
-On the basis of this staging, the patient will be classified according to a staging classification (the Ann Arbor staging classification scheme is a common one):
-* Stage I is involvement of a single lymph node region (I) or single extralymphatic site (Ie);
-* Stage II is involvement of two or more lymph node regions on the same side of the [[diaphragm (anatomy)|diaphragm]] (II) or of one lymph node region and a contiguous extralymphatic site (IIe);
-* Stage III is involvement of lymph node regions on both sides of the diaphragm, which may include the [[spleen]] (IIIs) and/or limited contiguous extralymphatic organ or site (IIIe, IIIes);
-* Stage IV is disseminated involvement of one or more extralymphatic organs.
-The absence of systemic symptoms is signified by adding 'A' to the stage; the presence of systemic symptoms is signified by adding 'B' to the stage.
 ==References==